A randomised trial of two information packages distributed to new cancer patients before their initial appointment at a regional cancer centre.

Autor: Mohide, EA, Whelan, TJ, Rath, D, Gafni, A, Willan, AR, Czukar, D, Campbell, IB, Okawara, GS, Neimanis, M, Levine, MN, Mohide, E A, Whelan, T J, Willan, A R, Campbell, I B, Okawara, G S, Levine, M N

Publikováno v: British Journal of Cancer; Jun1996, Vol. 73 Issue 12, p1588-1593, 6p

Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.

Autor: Swaminath A; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Parpia S; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Wierzbicki M; Juravinski Cancer Centre, Department of Medical Physics, McMaster University, Hamilton, Ontario, Canada., Kundapur V; Saskatchewan Cancer Agency, Department of Radiation Oncology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Faria S; Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Okawara GS; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Tsakiridis TK; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Ahmed N; Section of Radiation Oncology, Department of Radiology, Rady Faculty of Health Sciences, University of Manitoba and CancerCare Manitoba Research Institute, Winnipeg, Manitoba, Canada., Bujold A; Département de Radio-oncologie Clinique-Enseignement-Recherche, Centre intégré universitaire de soins et services sociaux de l'Est-de-l'Île-de-Montréal - Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada., Hirmiz K; Department of Radiation Oncology, Windsor Regional Cancer Centre, Windsor, Ontario, Canada., Owen T; Department of Oncology, Queen's University, Cancer Centre of Southeast Ontario at Kingston Health Sciences Centre, Kingston, Ontario, Canada., Leong N; Allan Blair Cancer Centre, Department of Radiation Oncology, University of Saskatchewan, Regina, Saskatchewan, Canada., Ramchandar K; Department of Oncology, Northern Ontario School of Medicine, Thunder Bay, Ontario, Canada., Filion E; Radiation Oncology Department, Centre Hospitalier de l'Université de Montréal, Notre Dame Hospital, Montreal, Quebec, Canada., Lau H; Department of Oncology, University of Calgary, Calgary, Alberta, Canada., Gabos Z; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Thompson R; Department of Radiation Oncology, Dalhousie University, Saint John, New Brunswick, Canada., Yaremko B; Department of Radiation Oncology, Western University, London, Ontario, Canada., Mehiri S; Département de Radio-oncologie, CISSS Montérégie, Hôpital Charles Lemoyne, Montreal, Quebec, Canada., Louie AV; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada., Quan K; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Levine MN; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Wright JR; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada., Whelan TJ; Department of Oncology, McMaster University, and the Division of Radiation Oncology Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Nov; Vol. 10 (11), pp. 1571-1575. Date of Electronic Publication: 2024 Sep 19.

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.

Autor: Hallemeier CL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Moughan J; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Haddock MG; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Herskovic AM; Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois., Minsky BD; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston., Suntharalingam M; Department of Radiation Oncology, University of Maryland and Greenebaum Comprehensive Cancer Center, Baltimore., Zeitzer KL; Department of Radiation Oncology, Albert Einstein Medical Center, Philadelphia, Pennsylvania., Garg MK; Department of Radiation Oncology, Montefiore Medical Center-Moses Campus, Bronx, New York., Greenwald BD; Department of Gastroenterology and Hepatology, University of Maryland and Greenebaum Cancer Center, Baltimore., Komaki RU; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston., Puckett LL; Department of Radiation Oncology, Medical College of Wisconsin and Zablocki Veterans' Administration Medical Center, Milwaukee., Kim H; Department of Radiation Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri., Lloyd S; Department of Radiation Oncology, University of Utah Health Science Center, Salt Lake City., Bush DA; Department of Radiation Oncology, Loma Linda University Cancer Institute, Loma Linda, California., Kim HE; Department of Radiation Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan., Lad TE; Department of Medical Oncology, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois., Meyer JE; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Okawara GS; Department of Radiation Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ontario, Canada., Raben A; Department of Radiation Oncology, Christiana Care Health Services Inc Community Clinical Oncology Program, Newark, Delaware., Schefter TE; Department of Radiation Oncology, University of Colorado, Aurora., Barker JL Jr; Department of Radiation Oncology, US Oncology Texas Oncology-Sugar Land, Fort Worth., Falkson CI; Department of Medicine, Hematology/Oncology, University of Rochester, Rochester, New York., Videtic GMM; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio., Jacob R; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham., Winter KA; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Crane CH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Apr 03; Vol. 6 (4), pp. e238504. Date of Electronic Publication: 2023 Apr 03.

Genome-wide host methylation profiling of anal and cervical carcinoma.

Autor: Siegel EM; Departments of Cancer Epidemiology, Tampa, FL, United States of America., Ajidahun A; Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, United States of America., Berglund A; Biostatistics and Bioinformatics, Tampa, FL, United States of America., Guerrero W; Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, United States of America., Eschrich S; Biostatistics and Bioinformatics, Tampa, FL, United States of America., Putney RM; Biostatistics and Bioinformatics, Tampa, FL, United States of America., Magliocco A; Anatomic Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States of America., Riggs B; Departments of Cancer Epidemiology, Tampa, FL, United States of America., Winter K; NRG Oncology Statistics and Data Management Center-ACR, Philadelphia, PA, United States of America., Simko JP; UCSF Medical Center-Mount Zion, San Francisco, CA, United States of America., Ajani JA; M D Anderson Cancer Center, Houston, TX, United States of America., Guha C; Montefiore Medical Center, New York, NY, United States of America., Okawara GS; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, United States of America., Abdalla I; Cancer Research for the Ozarks CCOP, Springfield, MO, United States of America., Becker MJ; Columbus Community Clinical Oncology Program, Columbus, OH, United States of America., Pizzolato JF; Mount Sinai Comprehensive Cancer Center CCOP, Miami, FL, United States of America., Crane CH; M D Anderson Cancer Center, Houston, TX, United States of America., Brown KD; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, United States of America., Shibata D; Department of Surgery, University of Tennessee Health Science Center, Memphis, TN, United States of America.

Publikováno v: PloS one [PLoS One] 2021 Dec 09; Vol. 16 (12), pp. e0260857. Date of Electronic Publication: 2021 Dec 09 (Print Publication: 2021).

Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.

Autor: Doll CM; Tom Baker Cancer Centre, Calgary, Alberta, Canada. Electronic address: Corinne.Doll@albertahealthservices.ca., Moughan J; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania., Klimowicz A; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Ho CK; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Kornaga EN; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Lees-Miller SP; University of Calgary, Calgary, Alberta, Canada., Ajani JA; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Crane CH; University of Texas M. D. Anderson Cancer Center, Houston, Texas., Kachnic LA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee., Okawara GS; McMaster University Juravinski Cancer Center, Hamilton Health Sciences, Hamilton, Ontario, Canada., Berk LB; Mount Sinai Comprehensive Cancer Center Community Clinical Oncology Program (CCOP), Miami Beach, Florida., Roof KS; Southeast Cancer Control Consortium, Inc, CCOP, Winston-Salem, North Carolina., Becker MJ; Columbus CCOP, Columbus, Ohio., Grisell DL; Greenville CCOP, Greenville, South Carolina., Ellis RJ; Cancer Research of the Ozarks, Springfield, Missouri., Sperduto PW; Metro-MN CCOP, St. Louis Park, Minnesota., Marsa GW; Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio., Guha C; Montefiore Medical Center, Bronx, New York., Magliocco AM; H. Lee Moffitt Cancer Center, Tampa, Florida.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2017 Mar 01; Vol. 97 (3), pp. 554-562. Date of Electronic Publication: 2016 Nov 23.